Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience

BACKGROUND: Glioblastoma is usually diagnosed around the age of 60–70 years. Patients older than 65 years are frequently described as “elderly”. Several trials with monotherapy have established treatment regimens that offer therapies with reduced side effects but reduced efficacy. We analysed the ou...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Radiat Oncol
Hoofdauteurs: Straube, Christoph, Scherb, Hagen, Gempt, Jens, Bette, Stefanie, Zimmer, Claus, Schmidt-Graf, Friederike, Schlegel, Jürgen, Meyer, Bernhard, Combs, Stephanie E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2017
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408447/
https://ncbi.nlm.nih.gov/pubmed/28454549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0809-9
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items